期刊文献+

超声心动图评估化疗药物致心脏毒性的现状及进展 被引量:12

下载PDF
导出
摘要 部分肿瘤化疗药物会导致心肌细胞损害或死亡,特别是总环类(Anthracyclines)和曲妥珠单抗(Trastuzumab)药物,其心脏毒性主要表现为左心室收缩功能不全,程度可以从亚临床的心功能不全到明显的心脏功能衰竭。不能早期识别潜在的化疗药物致心脏损伤,会影响患者的生存率和生活质量。若能在化疗早期及时以别心肌功能的变化,
出处 《中国医学影像学杂志》 CSCD 北大核心 2013年第10期787-790,共4页 Chinese Journal of Medical Imaging
基金 国家自然科学基金项目(81201095) 上海市卫生局卫生科技面上项目(20114192)
  • 相关文献

参考文献26

  • 1Garrone 0, Crosetto N, Lo Nigro C, et al. Prediction of anthracycline cardiotoxicity after chemotherapy by biomarkers kinetic analysis. Cardiovasc Toxicol, 2012,12(2): 135-142.
  • 2Cardinale D, Colombo A, Torrisi R, et al. Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation. J Clin Oncol, 20 I 0, 28(25): 3910-3916.
  • 3Fallah-Rad N, Walker JR, Wassef A, et al. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. J Am Coli Cardiol, 2011, 57(22): 2263-2270.
  • 4Cardinale D, Sandri MT, Colombo A, et al. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy. Circulation, 2004, 109(22): 2749-2754.
  • 5Mavinkurve-Groothuis AM, Groot-Loonen J, Bellersen L, et al. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines. Pediatr Blood Cancer, 2009, 52(5): 631-636.
  • 6Walker J, Bhullar N, fallah-Rad N, et al. Role of three-dimensional echocardiography in breast cancer: comparison with two?dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging. J Clin Oncol, 2010, 28(21): 3429-3436.
  • 7Takuma S, Ota T, Muro T, et al. Assessment of left ventricular function by real-time 3-dimensional echocardiography compared with conventional noninvasive methods. J Am Soc Echocardiogr, 2001,14(4): 275-284.
  • 8Lipshultz SE, Lipsitz SR, Sallan SE, et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol, 2005, 23(12): 2629- 2636.
  • 9Sorensen K, Levitt G, Bull C, et al. Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity. J Clin Oncol, 1997, 15( I): 61-68.
  • 10Stoddard MF, Seeger J, Liddell NE, et al. Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans. J Am Coli Cardiol, 1992, 20( I): 62-69.

同被引文献90

引证文献12

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部